Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can give you diarrhoea. It is one of the more commonly reported side effects, particularly in the first few weeks of treatment or after a dose increase. Most people find it settles as their body adjusts, but knowing why it happens and when to act makes a real difference. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber assesses whether it is suitable for you before any treatment begins. The NHS tirzepatide medicines page lists diarrhoea alongside other gastrointestinal effects as a known side effect of this treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is one of the most common things people describe in the early weeks. You started your first pen, or you moved up to 5mg, and now your stomach has its own opinions. That is frustrating, especially if you were already managing your expectations carefully. The honest answer is that it is usually temporary, and it has a straightforward explanation.
Tirzepatide slows the rate at which food leaves your stomach, a process called gastric emptying. It also acts on receptors throughout the gut. Both effects can shift how quickly digested food moves through the intestines, and for some people, particularly at the start, that produces loose stools or diarrhoea. It is a direct pharmacological consequence of how the medicine works, not a reaction indicating something has gone wrong.
The pattern most people report: symptoms are worst in the first one to two weeks after a new dose and then ease. Some people notice it mainly in the mornings; others find fatty or rich foods make it worse. Eating smaller portions, reducing very greasy meals, and keeping up fluid intake are practical steps that often help. If you want a fuller account of the bowel-related side effects that tirzepatide can cause, the Mounjaro diarrhoea overview goes into more detail.
Diarrhoea appears alongside nausea, constipation, indigestion and burping as part of a recognisable gastrointestinal profile for this class of medicine, none of which most people experience all at once.
Not everyone on Mounjaro gets diarrhoea. Among those who do, the severity varies considerably. A few factors seem to matter.
Dose matters most. The higher the dose, the stronger the effect on gastric emptying and gut motility, which is one reason the titration schedule starts at 2.5mg. Moving too quickly through doses before the body has adjusted is associated with more pronounced GI effects. This is worth bearing in mind if you are reading about tirzepatide diarrhoea and wondering why it happens at higher doses in particular.
Diet plays a role too. High-fat meals, very spicy foods, and large portions all tend to amplify GI side effects. Alcohol can compound the problem. Spacing meals more evenly and keeping portions moderate is not just good advice for weight management, it genuinely helps the gut side effects settle faster.
Individual gut sensitivity also varies. People with a history of irritable bowel syndrome or other GI conditions may notice effects more acutely; their prescriber should be aware of that history before treatment starts. The same applies to people on other medicines that affect gut motility.
For comparison, semaglutide (the medicine in Wegovy) can cause very similar effects, if you are researching the broader picture, how tirzepatide-specific diarrhoea compares is worth reading separately from the Wegovy side-effect profile.
Most cases are uncomfortable rather than dangerous. But there are specific situations where you should stop managing it at home and speak to a clinician.
Dehydration is the main risk with persistent diarrhoea. Signs to watch for include a dry mouth, noticeably reduced urination, feeling faint or dizzy, and dark urine. If you cannot keep fluids down or symptoms have lasted more than two to three days without any improvement, contact your prescriber or GP that day. Severe dehydration puts strain on the kidneys, and that is a clinical matter.
Severe, sudden abdominal pain (particularly pain that radiates towards your back) is a different signal altogether. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and severe stomach pain, with or without vomiting, is the key symptom to act on urgently. This is not the same as ordinary diarrhoea discomfort. If you experience it, seek medical help promptly rather than waiting to see if it passes.
Blood in the stool, a high temperature alongside diarrhoea, or diarrhoea that starts suddenly after weeks of having no GI symptoms at all are also reasons to get assessed rather than assume it is a routine side effect.
Our prescribers talk through side effects like these as part of the consultation, it is one of the things that makes clinical review more than a formality. You can read more about the full side-effect picture on the Mounjaro side effects page, or explore the eggy burps question if that has been bothering you too.
Diarrhoea from Mounjaro is manageable for most people, and the clinical review before you start is there to make sure your prescriber knows your full picture, any existing gut conditions, other medicines you take, and how to adjust if side effects become disruptive. That matters as much as the initial eligibility check.
Mounjaro is a prescription-only medicine. The legal route to it in the UK is a prescription following clinical assessment. At nume (at our pharmacy) a GPhC-registered Independent Prescriber reads your consultation the same day; it is a person, not a decision algorithm. If approved, treatment is dispatched the same day for free next-working-day tracked delivery. Aftercare is available seven days a week if side effects need discussing. You can start your free consultation whenever you are ready, or explore the Mounjaro treatment overview first if you want more context before deciding. Details on how we work are on our FAQs page.
If you are already on treatment elsewhere and thinking about moving, our clinical team can discuss how to transfer your care safely.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.